Sysmex Netherlands & Belgium’s Post

Join us on the 28th of May, from 17:00-18:00, for the webinar 'Breast cancer diagnostics today: Is a sensitive liquid biopsy the missing piece?'. This webinar, featuring leading expert Professor Nicola Fusco, explores the applications of liquid biopsy - a minimally invasive approach analysing tumor DNA circulating in blood. #BreastCancer #LiveWebinar #LiquidBiopsy #CaresphereAcademy #SysmexLifeScience #SysmexBNL

Did you know that CNB, or core needle biopsy, is an essential tool for diagnosing and staging breast cancer? By analyzing these samples, doctors can determine important characteristics of the cancer, such as the type, grade, hormone receptor status, and HER2 status. Find out everything you need to know about how CNBs are used in breast cancer diagnoses: https://lnkd.in/gpRsYgTC #disposablemedicaldevices #medicaleducation #medicaldevicemanufacturing #manufacturingprocess

In this latest episode of #OncLiveOnAir 🎙️, Stacey A. Cohen, MD, of Fred Hutch, discusses 🗣️ the evolving role of circulating tumor DNA in clinical decision-making for patients with colorectal cancer, particularly through findings from the CIRCULATE-Japan GALAXY trial. Tune in now 🎧 👉 : https://lnkd.in/eGcjWJ7d

Learn about all the misconceptions regarding extended endocrine therapy to treat HR+, early -stage breast cancer. And let’s not have women suffer with unnecessary side effects. Find out more with the link below:

There are several misconceptions regarding extended endocrine therapy to treat HR+, early-stage breast cancer. Learn the data. Find out more about the Breast Cancer Index test: https://bit.ly/3BC0U1i Hologic, Inc. #BreastCancerAwarenessMonth #Hologic #BustTheMyth #breastcancerindex

Enlightening read!

Continuing our #ExpertInsights series featuring Dr Francesco Giganti, what are the key 2024 prostate cancer diagnosis breakthroughs? Unsurprisingly, the first is the PI-CAI study that highlights the efficacy of AI in enhancing the accuracy of prostate cancer diagnostics: https://lnkd.in/gJCuVdty

In this new retrospective study published in July, two #AI-powered mammography solutions were evaluated head-to-head, to compare results of breast cancer detection. #ProFoundAI performed significantly better than the other solution for breast cancer detection, particularly in patients with non-dense breasts (AUC, 0.93; P < .001). Explore the study: https://bit.ly/3MOKxAx #EarlyDetection, #BreastAI, #iCAD, #RadiologyAI

I'm excited to announce that my article, "Tapping the Potential of Liquid Biopsy: Harnessing Urine for Advancing Cancer Diagnosis and Treatment with a Focus on Trans-renal Circulating Tumor DNA," has been published in the June 2024 edition of the AROI Newsletter. This piece explores innovative liquid biopsy techniques using urine samples and their impact on cancer diagnosis and treatment. Thank you, AROI, for featuring my work! #LiquidBiopsy #CancerDiagnosis #TransRenalCTDNA #MedicalResearch #AROINewsletter

October is #BreastCancerAwarenessMonth. Having dense breast tissue is a risk factor for developing breast cancer. The dense tissue can also mask tumors on a mammogram, making it more difficult to detect cancer early. Learn more about cancer screening challenges in the AACR #CancerProgressReport: https://bit.ly/3C4gNOf